rs751226641
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_006517.5(SLC16A2):āc.262A>Gā(p.Thr88Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000215 in 1,209,178 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_006517.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC16A2 | NM_006517.5 | c.262A>G | p.Thr88Ala | missense_variant | 1/6 | ENST00000587091.6 | NP_006508.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC16A2 | ENST00000587091.6 | c.262A>G | p.Thr88Ala | missense_variant | 1/6 | 1 | NM_006517.5 | ENSP00000465734 | P1 | |
SLC16A2 | ENST00000636771.1 | c.10A>G | p.Thr4Ala | missense_variant, NMD_transcript_variant | 1/7 | 5 | ENSP00000490445 |
Frequencies
GnomAD3 genomes AF: 0.0000355 AC: 4AN: 112767Hom.: 0 Cov.: 24 AF XY: 0.0000286 AC XY: 1AN XY: 34927
GnomAD3 exomes AF: 0.00000575 AC: 1AN: 174038Hom.: 0 AF XY: 0.0000159 AC XY: 1AN XY: 62944
GnomAD4 exome AF: 0.0000201 AC: 22AN: 1096411Hom.: 0 Cov.: 32 AF XY: 0.0000221 AC XY: 8AN XY: 362229
GnomAD4 genome AF: 0.0000355 AC: 4AN: 112767Hom.: 0 Cov.: 24 AF XY: 0.0000286 AC XY: 1AN XY: 34927
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 21, 2023 | The c.484A>G (p.T162A) alteration is located in exon 1 (coding exon 1) of the SLC16A2 gene. This alteration results from a A to G substitution at nucleotide position 484, causing the threonine (T) at amino acid position 162 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 01, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at